---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-025966"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2025-12-03T23:59:59+00:00"
generated_at: "2026-05-16T15:25:47.977495+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# ZyVersa director Robert Finizio resigns from board effective Dec 2, 2025

## Summary
- Independent director Robert G. Finizio resigned as board member, Compensation Committee chair, and Audit Committee member.
- Resignation effective immediately on December 2, 2025; accepted by the Board.
- Resignation was for personal reasons, not due to any disagreement with the Company on operations, policies, or practices.
- No replacement has been announced for the vacated board or committee positions.

## SEC filing metadata
- accession: 0001493152-25-025966
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2025-12-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000149315225025966/0001493152-25-025966-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000149315225025966/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-025966
- JSON: https://secwatch.observer/filing/0001493152-25-025966.json
- Plain text: https://secwatch.observer/filing/0001493152-25-025966.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.